 |
 |
 |
|
Comparison of Relative Bioavailability of TIVICAY Immediate Release and Dispersible Pediatric Tablets to Immediate Release TIVICAY Adult Tablets
|
|
|
Reported by Jules Levin
19th International Workshop on Clinical Pharmacology of Antiviral Therapy; May 22-24, 2018; Baltimore, MD
Parasrampuria R,1Adkison K,2Wolstenholme A,1Barthel S,3Davies M,3Buchanan A,2Singh R1
1GlaxoSmithKline, Collegeville, PA, USA; 2ViiV Healthcare, RTP, NC, USA; 3GlaxoSmithKline, Ware Hertfordshire, UK




|
|
|
 |
 |
|
|